Literature DB >> 33206041

Persistent Pseudomonas aeruginosa infection associated with non-invasive ventilation in a child with spinal muscular atrophy type 1.

Archana Chacko1, Peter D Sly1, Tim Kidd2, Leanne Gauld1,3.   

Abstract

NONE: Current standards of care suggest the use of non-invasive positive pressure ventilation (NIV) in children with spinal muscular atrophy and symptomatic respiratory failure. Theoretical concerns exist regarding NIV equipment as a source of infection in restrictive lung disease due to the possibility of prolonged NIV device use, greater risk in acquiring infections, and difficulties in managing and clearing infections. NIV devices may draw pathogens through the air inlet port that may contaminate the internal surfaces. These pathogens may then infect children with spinal muscular atrophy. We present a case of 2 genetically identical Pseudomonas aeruginosa cultures from both the patient's NIV device and from nasopharyngeal samples. This infection persisted both in nasopharyngeal aspirate cultures and from NIV equipment cultures despite the use of an eradication program involving both the child and the NIV device.
© 2021 American Academy of Sleep Medicine.

Entities:  

Keywords:  non-invasive ventilation; pseudomonas aeruginosa; spinal muscular atrophy type 1

Mesh:

Year:  2021        PMID: 33206041      PMCID: PMC7927343          DOI: 10.5664/jcsm.9014

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  9 in total

1.  Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.

Authors:  S Vassal; R Taamma; N Marty; A Sardet; P d'athis; F Brémont; M L Dalphin; P Plésiat; G Rault; J Thubert; S Dominique; J F Lemeland; J Derelle; M F Blech; M Roussey; M Perrin; A Sautegeau
Journal:  Am J Infect Control       Date:  2000-10       Impact factor: 2.918

2.  Is disinfection of mechanical ventilation tubing needed at home?

Authors:  Michel Toussaint; Marc Steens; André Van Zeebroeck; Philippe Soudon
Journal:  Int J Hyg Environ Health       Date:  2005-12-20       Impact factor: 5.840

3.  Infection prevention and control guideline for cystic fibrosis: 2013 update.

Authors:  Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-01       Impact factor: 3.254

4.  Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.

Authors:  Richard S Finkel; Eugenio Mercuri; Oscar H Meyer; Anita K Simonds; Mary K Schroth; Robert J Graham; Janbernd Kirschner; Susan T Iannaccone; Thomas O Crawford; Simon Woods; Francesco Muntoni; Brunhilde Wirth; Jacqueline Montes; Marion Main; Elena S Mazzone; Michael Vitale; Brian Snyder; Susana Quijano-Roy; Enrico Bertini; Rebecca Hurst Davis; Ying Qian; Thomas Sejersen
Journal:  Neuromuscul Disord       Date:  2017-11-23       Impact factor: 4.296

5.  [Bacterial colonization and home mechanical ventilation: prevalence and risk factors].

Authors:  J M Rodríguez González-Moro; G Andrade Vivero; J de Miguel Díez; S López Martín; C Sánchez; J L Izquierdo Alonso; P de Lucas Ramos
Journal:  Arch Bronconeumol       Date:  2004-09       Impact factor: 4.872

6.  Microbial contamination of nebulizers in the home treatment of cystic fibrosis.

Authors:  H Blau; H Mussaffi; M Mei Zahav; D Prais; M Livne; B M Czitron; H A Cohen
Journal:  Child Care Health Dev       Date:  2007-07       Impact factor: 2.508

7.  Microbial contamination of non-invasive ventilation devices used by adults with cystic fibrosis.

Authors:  A Mutagi; E F Nash; S Cameron; G Abbott; P Agostini; J L Whitehouse; D Honeybourne; E Boxall
Journal:  J Hosp Infect       Date:  2012-05-10       Impact factor: 3.926

8.  Respiratory Needs in Patients with Type 1 Spinal Muscular Atrophy Treated with Nusinersen.

Authors:  Valeria A Sansone; Alice Pirola; Emilio Albamonte; Marika Pane; Andrea Lizio; Adele D'Amico; Michela Catteruccia; Renato Cutrera; Claudio Bruno; Marina Pedemonte; Sonia Messina; Fabrizio Rao; Elisabetta Roma; Francesca Salmin; Giorgia Coratti; Alessandra Di Bari; Roberto De Sanctis; Carmela Maria Pera; Maria Sframeli; Marco Piastra; Francesco Macagno; Giuseppe Vita; Enrico Bertini; Eugenio Mercuri
Journal:  J Pediatr       Date:  2020-02-05       Impact factor: 4.406

9.  Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis.

Authors:  Luke D Knibbs; Graham R Johnson; Timothy J Kidd; Joyce Cheney; Keith Grimwood; Jacqueline A Kattenbelt; Peter K O'Rourke; Kay A Ramsay; Peter D Sly; Claire E Wainwright; Michelle E Wood; Lidia Morawska; Scott C Bell
Journal:  Thorax       Date:  2014-04-17       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.